Atlas Trials

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Clinical trial NCT00460265 · COMPLETED

Trial details

NCT number
NCT00460265
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent and/or Metastatic Head and Neck Cancer
Start date
2007-05-01
Primary completion
2010-05-01
Enrollment
658

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.